Mesothelin-Targeted Immunotherapy Pipeline Market Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
24 oct. 2024 10h15 HE
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Mesothelin-Targeted Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
World Immuno-Oncology Diagnostics Market Forecasts Report 2024: The Disruption Dynamic, The Race for Biomarkers, The Next Five Years
28 mai 2024 09h06 HE
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
NK Cell Therapies Pipeline Report 2024: Insights on 80+ Companies and 100+ Pipeline Drugs, Including ALECSAT (CytoVac), NKTR-214/Bempegaldesleukin (Nektar Therapeutics), and Monalizumab (Innate Pharma)
26 avr. 2024 04h12 HE
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "NK Cell Therapies - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Tumor Infiltrating Lymphocytes Industry Projected to Reach $18.32 Billion by 2028 - Emerging Technologies, such as cytoDRIVE, and Strategic Alliances Propelling the Global Market Forward
23 janv. 2024 09h43 HE
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Growth Driven by...
Global Natural Killer Cells Therapeutics Research Report 2023: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2022 and 2023-2028
03 janv. 2024 11h33 HE
|
Research and Markets
Dublin, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The "Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Immunotherapy Targeting Mesothelin: A Comprehensive 2023 Pipeline Review
14 déc. 2023 05h43 HE
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Mesothelin-Targeted Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. A groundbreaking review of...
Natural Killer Cells Therapeutics Market Analysis and Industry Forecast to 2027: Advancements in Manufacturing Processes, Cell Engineering Techniques and Development of Combination Therapies
07 août 2023 06h03 HE
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Natural Killer Cells Therapeutics Market by Therapeutics, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2027" report...
Global Web Analytics Market to Reach $13.92 Billion by 2027, Driven by Growing Demand for Online Shopping and Technological Advancements
14 juil. 2023 04h53 HE
|
Research and Markets
Dublin, July 14, 2023 (GLOBE NEWSWIRE) -- The "Urothelial Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global web analytics market is...
Tumor Infiltrating Lymphocytes Global Market Report 2023: Sector to Reach $15.56 Billion by 2027 at a 13.7% CAGR
23 mai 2023 04h53 HE
|
Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global tumor infiltrating...
Global Checkpoint Inhibitors Competitive Landscape Report 2023: Comprehensive Insights About 180+ Companies and 250+ Drug Profiles
08 mai 2023 06h48 HE
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Checkpoint inhibitors -...